Insider Trading & Ownership - Cline Christopher R.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Cline Christopher R.
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2025-04-11
Sale		 2025-04-14
6:23 pm		 Travere Therapeutics Inc. TVTX Cline Christopher R.
CHIEF FINANCIAL OFFICER		 48 $13.14 $631 89,990
(Direct)		 View
2025-02-03
Sale		 2025-02-04
8:30 pm		 Travere Therapeutics Inc. TVTX Cline Christopher R.
CHIEF FINANCIAL OFFICER		 5,192 $20.12 $104,463 148,038
(Direct)		 View
2025-01-22
Sale		 2025-01-23
8:33 pm		 Travere Therapeutics Inc. TVTX Cline Christopher R.
CHIEF FINANCIAL OFFICER		 865 $18.94 $16,384 73,730
(Direct)		 View
2024-09-09
Sale		 2024-09-09
9:20 pm		 Travere Therapeutics Inc. TVTX Cline Christopher R.
CHIEF FINANCIAL OFFICER		 2,490 $11.52 $28,685 74,595
(Direct)		 View
2024-09-04
Sale		 2024-09-05
9:30 pm		 Travere Therapeutics Inc. TVTX Cline Christopher R.
CHIEF FINANCIAL OFFICER		 514 $9.5093 $4,888 70,335
(Direct)		 View
2024-04-11
Sale		 2024-04-12
4:05 pm		 Travere Therapeutics Inc. TVTX Cline Christopher R.
CHIEF FINANCIAL OFFICER		 54 $6.74 $364 70,849
(Direct)		 View
2024-02-01
Sale		 2024-02-02
4:05 pm		 Travere Therapeutics Inc. TVTX Cline Christopher R.
CHIEF FINANCIAL OFFICER		 3,818 $8.5313 $32,573 135,903
(Direct)		 View
2024-01-23
Sale		 2024-01-25
4:10 pm		 Travere Therapeutics Inc. TVTX Cline Christopher R.
CHIEF FINANCIAL OFFICER		 853 $9.0684 $7,735 49,721
(Direct)		 View
2023-09-05
Sale		 2023-09-05
8:15 pm		 Travere Therapeutics Inc. TVTX Cline Christopher R.
Chief Financial Officer		 457 $14.71 $6,723 50,574
(Direct)		 View
2023-05-10
Sale		 2023-05-12
4:14 pm		 Travere Therapeutics Inc. TVTX Cline Christopher R.
Chief Financial Officer		 455 $16.59 $7,548 51,031
(Direct)		 View
2023-04-11
Sale		 2023-04-13
4:07 pm		 Travere Therapeutics Inc. TVTX Cline Christopher R.
Chief Financial Officer		 47 $21.49 $1,010 51,486
(Direct)		 View
2023-02-01
Sale		 2023-02-02
7:02 pm		 Travere Therapeutics Inc. TVTX Cline Christopher R.
Chief Financial Officer		 1,588 $21.75 $34,542 112,783
(Direct)		 View
2023-01-24
Sale		 2023-01-26
4:05 pm		 Travere Therapeutics Inc. TVTX Cline Christopher R.
Chief Financial Officer		 852 $21.9 $18,663 32,871
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2025-01-31
Option Award		 2025-02-04
8:30 pm		 N/A
2035-01-31		 Travere Therapeutics Inc. TVTX Cline Christopher R.
CHIEF FINANCIAL OFFICER		 79,500 $0 148,038
(Direct)		 View
2024-09-05
Option Award		 2024-09-09
9:20 pm		 N/A
N/A		 Travere Therapeutics Inc. TVTX Cline Christopher R.
CHIEF FINANCIAL OFFICER		 6,750 $0 74,595
(Direct)		 View
2024-01-31
Option Award		 2024-02-02
4:05 pm		 N/A
2034-01-30		 Travere Therapeutics Inc. TVTX Cline Christopher R.
CHIEF FINANCIAL OFFICER		 90,000 $0 135,903
(Direct)		 View
2023-01-31
Option Award		 2023-02-02
7:02 pm		 N/A
2033-01-30		 Travere Therapeutics Inc. TVTX Cline Christopher R.
Chief Financial Officer		 81,500 $0 112,783
(Direct)		 View
2022-09-01
Option Award		 2022-09-01
6:20 pm		 N/A
2032-08-31		 Travere Therapeutics Inc. TVTX Cline Christopher R.
Chief Financial Officer		 62,840 $0 91,563
(Direct)		 View

Ownership		 2022-09-01
6:19 pm		 N/A
N/A		 Travere Therapeutics Inc. TVTX Cline Christopher R.
Chief Financial Officer		 0 $0 197,473
(Direct)		 View